ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EDEN Eden Research Plc

4.35
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.35 4.20 4.50 4.35 4.35 4.35 0.00 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.36 23.2M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.35p. Over the last year, Eden Research shares have traded in a share price range of 3.675p to 7.625p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £23.20 million. Eden Research has a price to earnings ratio (PE ratio) of -10.36.

Eden Research Share Discussion Threads

Showing 15401 to 15416 of 18525 messages
Chat Pages: Latest  621  620  619  618  617  616  615  614  613  612  611  610  Older
DateSubjectAuthorDiscuss
15/8/2023
15:58
The more you shout, the more desperate you sound. It is quite sad really and immensely amusing. You should also expand your horizons - far better resturants than Langans!!!
kittybiscuits
15/8/2023
13:50
Your welcome Gemstar.

Another important point is how the market is being primed for the big moves into biologicals which were not happening five years ago and the likes of Corteva and Syngenta did not have the capability to build out biologicals as they do now that purpose built hubs have been constructed.

Five years ago the market was not ready and the climate change narrative was not as well embedded and corporately choreographed and fact checked to be compliant with Tara Lu and UN 2030 targets but now it is and the PR confirms the direction of travel.. bought to you by the UK state broadcaster.. Pravda..so it's got to be true.


Syngenta Biologicals Syngenta Biologicals
58,266


The effects of climate change are happening now: we already see effects scientists predicted, such as more intense heat waves, draught, more severe stormings, and declining crop yields.
That's why farmers need valuable solutions to preserve their harvest and ensure food production.

Watch the video created by BBC Storyworks for Syngenta and find out how biologicals help farmers to overcome the effects of climate change.

supersonico
15/8/2023
13:47
Nous attendons l'escalier a 30,35 pEt apres , Beacoup de livre .
alchemy
15/8/2023
12:02
Ah, gemstar2 part of the multiavatar gang of two, or merely terminally stupid?

That such people exist in the market is ................. scrumptious!

;D

neutralpov
15/8/2023
07:42
Thanks Supersonico for that informative answer
gemstar2
14/8/2023
22:13
Hey Liar, why aren’t you publishing my IP address. Could it be you lied and don’t actually have it.
kittybiscuits
14/8/2023
19:39
That's a bit de trop even for you ,
alchemy
14/8/2023
16:07
Gemstar,

Currently Peanuts in ££ terms and in relation to directors pay etc ( which I sense is the irritation you have with Brooks etal and your 'properly commercialised' issue..fair enough , your not alone ) but can be seen as foundational as part of establishing , enhancing loading capacity and tweaking chemistry / IP including achieving approval of three essential oils substances upon which SustainE with conventional pesticides and Eden's Insecticide will be based which will return high revenues to the company and that ramp up starts this year with the EUA of the seed treatment.

Take Mevalone as an example and consider the new 10x strategy that is built upon many years of foundational work of a product that I imagine you don't consider 'properly commercialised'. Without that investment and valuable knowledge base multiplier Corteva would not be interested imo.

It is also my belief that the move into our own lab gave Eden far more leverage, sovereignty and influence over decision making which has meant more investment at the front end but greater revenues going forward..hopefully.

That's why in all seriousness it should be different this time next year..rodney.

supersonico
14/8/2023
15:56
What is the annual income from these two products?
gemstar2
14/8/2023
09:49
Gemstar.

What's your answer to your question? and can you tell me why you don't consider Mevalone and Cedroz 'properly commercialised'?

supersonico
14/8/2023
09:24
I guess the question is, why after 10 years of licences, regulatory consents etc, they have still not properly commercialised a single product?
gemstar2
14/8/2023
09:14
The NaturalBornLiar is obsessed.
kittybiscuits
13/8/2023
23:13
I live rent free in Lube’s head.
supersonico
13/8/2023
16:04
Gemstar,
I imagine Abrey will more likely give you an answer to that question if your actually after an answer or perhaps your asking here to make some sort of other point, which if that is the case why don't you make your point less opaque, especially for those who don't know Eden's history ?

supersonico
13/8/2023
14:02
But is Eden making any contribution to that?!

Not yet..but hopefully in*the*coming.

supersonico
13/8/2023
12:14
So now you see it and pay for it
Now you don't

So much excitement when Eden was first linked to Bayer

Where IS Brooks?

gemstar2
Chat Pages: Latest  621  620  619  618  617  616  615  614  613  612  611  610  Older

Your Recent History

Delayed Upgrade Clock